Guardant Health (GH) reported preliminary Q4 revenue of $280M, up 39% year over year and modestly above the consensus estimate of $267.75M, driven by strong oncology and screening volumes. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback